Insider Holders & Insider Ownership - AGIOS PHARMACEUTICALS INC. (AGIO)

List of insiders holdings for AGIOS PHARMACEUTICALS INC.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
CELGENE CORP
Celgene European Investment Co LLC
Celgene Switzerland LLC
Celgene Alpine Investment Co. LLC
10% Owner
2019-11-14 16:07:117,121,658
0
7,121,658Form 13D
STARR KEVIN P
Director
10% Owner
2015-02-19 19:01:33342,253
4,590,480
4,932,733Form 4
THIRD ROCK VENTURES LP
Third Rock Ventures GP L.P.
TRV GP LLC
10% Owner
2015-02-19 19:03:374,590,480
0
4,590,480Form 4
Flagship Ventures Fund 2007 L.P.
AFEYAN NOUBAR
KANIA EDWIN M JR
Flagship Ventures 2007 General Partner LLC
10% Owner
2017-02-13 14:25:03965,369
0
965,369Form 13G
Mak Tak W.
10% Owner
2013-07-23 20:23:06545,454
0
545,454Form 3
Higgons John Duncan
Chief Operating Officer
2016-01-05 17:20:30483,035
0
483,035Form 4
Cantley Lewis Clayton Jr.
Director
2017-12-08 16:23:4279,475
121,121
200,596Form 4
Hoerter Steven L.
Chief Commercial Officer
2019-03-05 16:04:05117,241
0
117,241Form 4
NELSEN ROBERT
Director
2017-03-07 16:35:15109,230
0
109,230Form 4
Goddard Glenn
Senior Vice President, Finance
2016-02-18 17:15:42108,572
0
108,572Form 4
Goff Brian
Chief Executive Officer
2024-08-12 17:15:31101,483
0
101,483Form 4
Biller Scott
Chief Scientific Officer
2019-06-13 16:07:4233,729
53,059
86,788Form 4
Milanova Tsveta
Chief Commercial Officer
2024-03-05 16:06:3877,000
0
77,000Form 4
Gheuens Sarah
Chief Medical Officer
2024-07-03 16:30:0860,485
0
60,485Form 4
Ballal Rahul D.
Director
2024-11-12 16:09:3853,886
0
53,886Form 4
Biller Jonathan
Chief Financial Officer
2022-03-03 16:12:1952,500
0
52,500Form 4
Car Bruce
Chief Scientific Officer
2022-03-03 16:11:4652,500
0
52,500Form 4
Tessier-Lavigne Marc
Director
2016-06-23 16:10:1848,875
0
48,875Form 4
Scadden David
Director
2024-12-13 16:04:4144,590
0
44,590Form 4
Hirsch Andrew
Chief Financial Officer
2020-04-24 16:06:3636,057
0
36,057Form 4
Clancy Paul J
Director
2022-06-23 16:09:4034,282
0
34,282Form 4
MARAGANORE JOHN
Director
2023-02-03 16:06:0328,528
0
28,528Form 5
Jones Cecilia
Chief Financial Officer
2024-09-30 16:15:2927,630
0
27,630Form 4
KARSEN PERRY A
Director
2015-06-25 18:26:5323,125
0
23,125Form 4
Bowden Christopher
Chief Medical Officer
2021-06-22 16:44:1916,479
0
16,479Form 4
Burns James William
Chief Legal Officer
2024-11-12 16:08:1515,700
0
15,700Form 4
Ho Maykin
Director
2024-06-24 16:10:0113,894
0
13,894Form 4
FOUSE JACQUALYN A
Director
2024-06-24 16:10:5613,894
0
13,894Form 4
CAPELLO JEFFREY D
Director
2024-06-24 16:10:3513,894
0
13,894Form 4
Foster-Cheek Kaye I
Director
2024-06-24 16:10:1113,894
0
13,894Form 4
Owen Catherine E.
Director
2024-06-24 16:09:5013,894
0
13,894Form 4
Schenkein David P
Director
2024-06-24 16:09:4013,894
0
13,894Form 4
Smith Cynthia
Director
2024-08-13 16:12:4010,294
0
10,294Form 4
Poddar Richa
Chief Commercial Officer
2022-10-18 16:17:108,508
0
8,508Form 4
Miles Darrin
Chief Commercial Officer
2021-05-18 16:11:407,209
0
7,209Form 4
CLARK IAN T
Director
2022-05-24 16:12:106,549
0
6,549Form 4
Cole Douglas G.
Director
2016-08-11 16:33:473,695
0
3,695Form 4
Alenson Carman
Principal Accounting Officer
2021-06-23 17:28:443,555
0
3,555Form 4
Washburn Theodore James Jr.
Principal Accounting Officer
2024-11-13 16:14:37813
0
813Form 4
Arch Venture Fund VII LP
ARCH Venture Partners VII L.P.
ARCH Venture Partners VII LLC
CRANDELL KEITH
BYBEE CLINTON
10% Owner
2016-02-11 12:24:080
0
0Form 13G